Suppr超能文献

食管黏膜下腺的坏死性唾液腺化生样改变与 Barrett 食管有关。

Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.

机构信息

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 1364 Clifton Road NE, Room H-188, Atlanta, GA, 30322, USA,

出版信息

Virchows Arch. 2014 Aug;465(2):135-43. doi: 10.1007/s00428-014-1590-x. Epub 2014 May 27.

Abstract

The esophageal submucosal glands (SMG) protect the squamous epithelium from insults such as gastroesophageal reflux disease by secreting mucins and bicarbonate. We have observed metaplastic changes within the SMG acini that we have termed oncocytic glandular metaplasia (OGM), and necrotizing sialometaplasia-like change (NSMLC). The aim of this study is to evaluate the associated clinicopathological parameters of, and to phenotypically characterize the SMG metaplasias. Esophagectomy specimens were retrospectively assessed on hematoxylin and eosin sections and assigned to either a Barrett's esophagus (BE) or non-BE control group. Clinicopathologic data was collected, and univariate analysis and multivariate logistic regression models were performed to assess the adjusted associations with NSMLC and OGM. Selected cases of SMG metaplasia were characterized. SMG were present in 82 esophagi that met inclusion criteria. On univariate analysis, NSMLC was associated with BE (p = 0.002). There was no relationship between NSMLC and patient age, sex, tumor size, or treatment history. OGM was associated with BE (p = 0.031). No relationship was found between OGM and patient age, sex, or tumor size. On multivariate analysis, BE was independently associated with NSMLC (odds ratio [OR] 4.95, p = 0.003). Treatment history was also independently associated with OGM (p = 0.029), but not NSMLC. Both NSMLC and OGM were non-mucinous ductal type epithelia retaining a p63-smooth muscle actin co-positive myoepithelial cell layer. NSMLC and OGM were present in endoscopic mucosal resection specimens. Our study suggests that SMG metaplasia is primarily a reflux-induced pathology. NSMLC may pose diagnostic dilemmas in resection specimens or when only partially represented in mucosal biopsies or endoscopic resection specimens.

摘要

食管黏膜下腺(SMG)通过分泌黏液和碳酸氢盐来保护鳞状上皮免受胃食管反流病等刺激。我们观察到 SMG 腺泡内发生的化生改变,我们称之为嗜酸细胞性腺性化生(OGM)和坏死性唾液腺样化生样改变(NSMLC)。本研究旨在评估与 SMG 化生相关的临床病理参数,并对其进行表型特征分析。对苏木精和伊红切片的食管切除术标本进行回顾性评估,并分为 Barrett 食管(BE)或非 BE 对照组。收集临床病理数据,并进行单因素分析和多变量逻辑回归模型,以评估与 NSMLC 和 OGM 相关的调整关联。对 SMG 化生的选定病例进行了特征描述。符合纳入标准的 82 例食管存在 SMG。单因素分析显示,NSMLC 与 BE 相关(p = 0.002)。NSMLC 与患者年龄、性别、肿瘤大小或治疗史之间无关系。OGM 与 BE 相关(p = 0.031)。OGM 与患者年龄、性别或肿瘤大小之间未发现关系。多变量分析显示,BE 与 NSMLC 独立相关(比值比 [OR] 4.95,p = 0.003)。治疗史也与 OGM 独立相关(p = 0.029),但与 NSMLC 无关。NSMLC 和 OGM 均为非黏液性导管型上皮,保留 p63-平滑肌肌动蛋白共阳性的肌上皮细胞层。NSMLC 和 OGM 存在于内镜黏膜切除术标本中。我们的研究表明,SMG 化生主要是一种反流诱导的病理。在切除标本中,或仅在黏膜活检或内镜切除标本中部分表现时,NSMLC 可能会引起诊断难题。

相似文献

1
Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.
Virchows Arch. 2014 Aug;465(2):135-43. doi: 10.1007/s00428-014-1590-x. Epub 2014 May 27.
2
Hyperplasia of the submucosal glands of the columnar-lined oesophagus.
Histopathology. 2015 Apr;66(5):726-31. doi: 10.1111/his.12604. Epub 2015 Jan 20.
3
Mucin histochemistry of esophagus in health and malignancy.
Indian J Gastroenterol. 1997 Oct;16(4):140-1.
4
[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Zentralbl Chir. 2004 Apr;129(2):99-103. doi: 10.1055/s-2004-816278.
5
Submucosal glands in the columnar-lined oesophagus: evidence of an association with metaplasia and neosquamous epithelium.
Histopathology. 2012 Jul;61(1):53-8. doi: 10.1111/j.1365-2559.2012.04180.x. Epub 2012 Mar 28.
6
Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
Arch Surg. 1994 Jun;129(6):609-14. doi: 10.1001/archsurg.1994.01420300051007.
7
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.
Am J Surg Pathol. 2005 Mar;29(3):372-80. doi: 10.1097/01.pas.0000147403.33509.de.
8
"Glassy" cells in Barrett's mucosa.
Anticancer Res. 2009 Oct;29(10):4145-6.
9
Pathophysiology of Barrett's esophagus.
Semin Thorac Cardiovasc Surg. 1997 Jul;9(3):270-8.

引用本文的文献

1
Esophageal intramural pseudodiverticulosis.
World J Gastroenterol. 2024 Jan 14;30(2):137-145. doi: 10.3748/wjg.v30.i2.137.
2
Esophageal Intramural Pseudodiverticulosis: A Histopathological and Immunohistochemical Study of 2 Cases.
Case Rep Gastroenterol. 2022 Apr 28;16(1):270-277. doi: 10.1159/000524496. eCollection 2022 Jan-Apr.
3
Pathogenesis and Cells of Origin of Barrett's Esophagus.
Gastroenterology. 2019 Aug;157(2):349-364.e1. doi: 10.1053/j.gastro.2019.03.072. Epub 2019 May 10.
5
Dysplasia discrimination in intestinal-type neoplasia of the esophagus and colon via digital image analysis.
Virchows Arch. 2016 Oct;469(4):405-15. doi: 10.1007/s00428-016-1999-5. Epub 2016 Aug 5.
6
Ductal metaplasia in oesophageal submucosal glands is associated with inflammation and oesophageal adenocarcinoma.
Histopathology. 2015 Dec;67(6):771-82. doi: 10.1111/his.12707. Epub 2015 Jun 4.
7
Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.
Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):3-16. doi: 10.1016/j.bpg.2014.11.001. Epub 2014 Nov 12.

本文引用的文献

1
The clinical, histologic, and treatment spectrum in necrotizing sialometaplasia.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Nov;114(5):577-85. doi: 10.1016/j.oooo.2012.02.020. Epub 2012 Aug 22.
2
Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.
Drugs. 2011 Dec 24;71(18):2381-9. doi: 10.2165/11597300-000000000-00000.
3
Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.
Nat Rev Gastroenterol Hepatol. 2011 Nov 22;9(1):15-22. doi: 10.1038/nrgastro.2011.210.
4
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study.
Aliment Pharmacol Ther. 2012 Jan;35(1):154-64. doi: 10.1111/j.1365-2036.2011.04901.x. Epub 2011 Nov 9.
5
The role of mucin in GERD and its complications.
Nat Rev Gastroenterol Hepatol. 2011 Nov 8;9(1):55-9. doi: 10.1038/nrgastro.2011.211.
6
Advancements in the analysis of esophageal pH monitoring in GERD.
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):101-7. doi: 10.1038/nrgastro.2010.212.
7
GERD in 2010: diagnosis, novel mechanisms of disease and promising agents.
Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):73-4. doi: 10.1038/nrgastro.2010.220.
8
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.
Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773.
10
Is the course of gastroesophageal reflux disease progressive? A 21-year follow-up.
Scand J Gastroenterol. 2009;44(11):1277-87. doi: 10.3109/00365520903314157.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验